Federal Circuit Refuses Rehearing Of Homocysteine Assay Patent Case
"CTT and its clients have successfully prevailed in multiple venues in this important case. We applaud the Court of Appeals for the Federal Circuit’s decision to reaffirm the lower court's decision and will work with LabCorp for a final licensing agreement,” John B. Nano, CTT's President and CEO, said in a statement....
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login